These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22140620)

  • 1. The genetics of pulmonary arterial hypertension in the post-BMPR2 era.
    Fessel JP; Loyd JE; Austin ED
    Pulm Circ; 2011; 1(3):305-19. PubMed ID: 22140620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
    Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
    Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
    Happé C; Kurakula K; Sun XQ; da Silva Goncalves Bos D; Rol N; Guignabert C; Tu L; Schalij I; Wiesmeijer KC; Tura-Ceide O; Vonk Noordegraaf A; de Man FS; Bogaard HJ; Goumans MJ
    Cells; 2020 Jun; 9(6):. PubMed ID: 32521690
    [No Abstract]   [Full Text] [Related]  

  • 4.
    Song J; Hinderhofer K; Kaufmann LT; Benjamin N; Fischer C; Grünig E; Eichstaedt CA
    Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33036198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Advances in Modifying BMPR2 Signaling in PAH.
    Dannewitz Prosseda S; Ali MK; Spiekerkoetter E
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic linkage analysis of a large family identifies
    Puigdevall P; Piccari L; Blanco I; Barberà JA; Geiger D; Badenas C; Milà M; Castelo R; Madrigal I
    J Med Genet; 2019 Jul; 56(7):481-490. PubMed ID: 30894412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension.
    Hong KH; Lee YJ; Lee E; Park SO; Han C; Beppu H; Li E; Raizada MK; Bloch KD; Oh SP
    Circulation; 2008 Aug; 118(7):722-30. PubMed ID: 18663089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of pulmonary arterial hypertension following medication and shunt closure in a
    Suzuki H; Hanawa H; Torigoe T; Sato S
    J Cardiol Cases; 2017 Jul; 16(1):11-13. PubMed ID: 30279786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension.
    McMurtry MS; Moudgil R; Hashimoto K; Bonnet S; Michelakis ED; Archer SL
    Am J Physiol Lung Cell Mol Physiol; 2007 Apr; 292(4):L872-8. PubMed ID: 17142350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCUBE1 Controls BMPR2-Relevant Pulmonary Endothelial Function: Implications for Diagnostic Marker Development in Pulmonary Arterial Hypertension.
    Sun W; Tang Y; Tai YY; Handen A; Zhao J; Speyer G; Al Aaraj Y; Watson A; Romanelli ME; Sembrat J; Rojas M; Simon MA; Zhang Y; Lee J; Xiong Z; Dutta P; Vasamsetti SB; McNamara D; McVerry B; McTiernan CF; Sciurba FC; Kim S; Smith KA; Mazurek JA; Han Y; Vaidya A; Nouraie SM; Kelly NJ; Chan SY
    JACC Basic Transl Sci; 2020 Nov; 5(11):1073-1092. PubMed ID: 33294740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMPR2-expressing bone marrow-derived endothelial-like progenitor cells alleviate pulmonary arterial hypertension in vivo.
    Harper RL; Maiolo S; Ward RJ; Seyfang J; Cockshell MP; Bonder CS; Reynolds PN
    Respirology; 2019 Nov; 24(11):1095-1103. PubMed ID: 30977250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genes in pediatric pulmonary arterial hypertension and the most promising
    Dai L; Du L
    Front Genet; 2022; 13():961848. PubMed ID: 36506323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Endothelial Bone Morphogenetic Protein Receptor Type 2 Activity by Vascular Endothelial Growth Factor Receptor 3 in Pulmonary Arterial Hypertension.
    Hwangbo C; Lee HW; Kang H; Ju H; Wiley DS; Papangeli I; Han J; Kim JD; Dunworth WP; Hu X; Lee S; El-Hely O; Sofer A; Pak B; Peterson L; Comhair S; Hwang EM; Park JY; Thomas JL; Bautch VL; Erzurum SC; Chun HJ; Jin SW
    Circulation; 2017 Jun; 135(23):2288-2298. PubMed ID: 28356442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of genetics in pulmonary arterial hypertension.
    Ma L; Chung WK
    J Pathol; 2017 Jan; 241(2):273-280. PubMed ID: 27770446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
    Feng F; Harper RL; Reynolds PN
    Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic basis of pulmonary arterial hypertension: current understanding and future directions.
    Newman JH; Trembath RC; Morse JA; Grunig E; Loyd JE; Adnot S; Coccolo F; Ventura C; Phillips JA; Knowles JA; Janssen B; Eickelberg O; Eddahibi S; Herve P; Nichols WC; Elliott G
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):33S-39S. PubMed ID: 15194176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
    Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
    Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathogenesis and current pathology of pulmonary hypertension.
    de Jesus Perez VA
    Heart Fail Rev; 2016 May; 21(3):239-57. PubMed ID: 26694808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary arterial hypertension drugs can partially restore altered angiogenic capacities in
    Tielemans B; Wagenaar A; Belge C; Delcroix M; Quarck R
    Pulm Circ; 2023 Oct; 13(4):e12293. PubMed ID: 37790139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.